|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The pharmacokinetics of vardenafil, a new selective PDE5 inhibitor, is minimally affected by coadministration with cimetidine or ranitidine 显示文摘 | Rohde G Wensing G Unger S | 2001 | Pharmacotherapy2001，21，10： | 1 |
| 2 | The interaction of alcohol with vardenafil, a potent and highly selective phosphodiesterase type 5 inhibitor 显示文摘 | Bauer RJ Rohde G Wensing G | 2002 | Pharmacotherapy2002，22，3： | 1 |
| 3 | Prevalence of drug-resistant HIV-1 variants in untreated individuals in Eu- rope: implications for clinical management显示文摘 | Wensing AM van de Vijver DA Angarano G | 2005 | J Infect Dis2005，192，6： | 1 |
| 4 | Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management 显示文摘 | Wensing AM Van de Vijver DA Angarano G | 2005 | J Infect Dis2005，192，6： | 1 |
| 5 | Prevalence of drug-resistant HIV-1 variants in intreated individuals in Europe:Implications for clinical management显示文摘 | Wensing AMJ Vijver DA Angarano G | 2005 | J Infec Dis2005，192，： | 1 |
| 6 | Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries显示文摘 | Pasterkamp G Wensing PJ Post MJ | | 0，，： | 1 |
| 7 | Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management 显示文摘 | Wensing AM Van de Vijver DA Angarano G | 2005 | J Infec Dis2005，192，6： | 1 |
| 8 | Efficient immunocastration of male piglets by immunoneutralization of GnRH using a new GnRH-like peptide显示文摘 | Meloen R H Turkstra J A Lankhof H Puijk W C Schaaper W M Dijkstra G Wensing C J Oonk R B | 1994 | Vaccine1994，12，8： | 1 |
| 9 | Safety, pharmaco- dynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor X a inhibitor--after multiple dosing in healthy male subjects 显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，： | 1 |
| 10 | Safety, pharma- codynamics, and pharmacokinetics of BAY 59-7939 an o- ral, direct factor X a inhibitor - after multiple dosing in healthy male subjects 显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 11 | Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939-an oral, direct Factor Xa inhibitor-after multiple dosing in healthy male subjects 显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 12 | The dynamic behaviour of a system that includes a rolling bearing显示文摘 | Wensing J A van Nijen G C | | 0，，： | 1 |
| 13 | The influence of lubrication on the dynamic behavior of ball bearings 显示文摘 | Wijnant Y H Wensing J A Van Nijen G C | 1999 | Journal of Sound and Vibration1999，，4： | 1 |
| 14 | The pathogenesis of the post-weaning syndrome in weaned piglets,a review显示文摘 | Van Beers-Schreurs H M G Vellenga L Wensing T | | 0，，： | 1 |
| 15 | Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications forclinical management 显示文摘 | Wensing AM van de \jver DA Angarano G | 2005 | J Infect Dis2005，192，6： | 1 |
| 16 | Safety, pharmacodynam- ics, and pharmacokinetics of BAY 59 - 7939 - an oral, direct fac tor X ainhibitor - after multiple dosing in healthy male subjects 显示文摘 | Kubitza D Becka M Wensing G | 2005 | Eur J Clin Pharmacol2005，61，12： | 1 |
| 17 | Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerot-ic femoral arteries显示文摘 | Pasterkamp G Wensing PJ Post MJ | 1995 | Circulation1995，91，5： | 1 |
| 18 | Shared decision making:developing the OPTION scale for measuring patient involvement显示文摘 | Elwyn G Edwards A Wensing M | 2003 | Quality and Safety in Health Care2003，12，2： | 1 |
| 19 | Effects of cadmium on some clinical and biochemical measurements in heifers显示文摘 | Wenlink G H Wensing T Bars A J | 1988 | Bull Environ Contain Toxicol1988，40，： | 1 |
| 20 | Dependence on theCCR5 coreceptor for viral replication explains the lack ofrebound of CXCR4-predicted HIV variants in the Berlinpatient 显示文摘 | Symons J Vandekerckhove L Hutter G Wensing AM van Ham PM Deeks SG Nijhuis M | 2014 | Clin Infect Dis2014，59，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员